Autoimmune disease drugs
These companies develop drugs that calm the immune system in diseases like lupus, rheumatoid arthritis and vasculitis.
+42.3%
over 1 year · S&P 500 +11.6%
Key indicators
Health
50 / 100
Fragile
Solid
Price
P/E 25
Cheap
Expensive
Up over 1 year
30 of 46
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 52 companies
LLY
+42.7%
JNJ
+50.3%
ABBV
+29.5%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
L
Eli Lilly
LLY
51.6%
+42.7%
J
Johnson & Johnson
JNJ
25.5%
+50.3%
A
AbbVie
ABBV
20.0%
+29.5%
K
Kymera Therapeutics
KYMR
0.4%
+100.8%
S
Spyre Therapeutics
SYRE
0.4%
+343.9%
T
TG Therapeutics
TGTX
0.4%
+108.0%
I
Immunovant
IMVT
0.3%
+45.8%
O
Oruka Therapeutics
ORKA
0.3%
+272.3%
D
Dianthus Therapeutics
DNTH
0.2%
+137.1%
V
Viridian Therapeutics
VRDN
0.1%
+6.7%
X
Xencor
XNCR
0.1%
+157.7%
C
Celldex Therapeutics
CLDX
<0.1%
+18.9%
T
First Tracks Biotherapeutics
TRAX
<0.1%
Z
Zenas BioPharma
ZBIO
<0.1%
−21.8%
N
Nektar Therapeutics
NKTR
<0.1%
−35.4%
V
Vor Biopharma
VOR
<0.1%
+93.0%
J
Jade Biosciences
JBIO
<0.1%
+61.4%
O
Odyssey Therapeutics
ODTX
<0.1%
C
Corvus Pharmaceuticals
CRVS
<0.1%
+30.1%
G
Monte Rosa Therapeutics
GLUE
<0.1%
−33.8%
A
Alumis
ALMS
<0.1%
+6.9%
C
Cullinan Therapeutics
CGEM
<0.1%
+23.1%
A
Attovia Therapeutics
ATTO
<0.1%
C
Climb Bio
CLYM
<0.1%
+439.6%
A
Aclaris Therapeutics
ACRS
<0.1%
+62.7%
S
Shattuck Labs
STTK
<0.1%
+142.2%
A
Avalo Therapeutics
AVTX
<0.1%
−49.7%
C
Cabaletta Bio
CABA
<0.1%
−47.8%
E
Enanta Pharmaceuticals
ENTA
<0.1%
−7.9%
K
Kyverna Therapeutics
KYTX
<0.1%
−31.1%
E
Evommune
EVMN
<0.1%
−60.9%
Q
Q32 Bio
QTTB
<0.1%
+258.4%
A
Artiva Biotherapeutics
ARTV
<0.1%
+0.8%
P
Palisade Bio
PALI
<0.1%
−45.1%
Y
Yarrow Bioscience
YARW
<0.1%
+86.4%
F
Fate Therapeutics
FATE
<0.1%
+23.1%
Z
Zura Bio
ZURA
<0.1%
−73.2%
C
Cue Biopharma
CUE
<0.1%
−19.5%
A
Adicet Bio
ACET
<0.1%
−74.7%
A
Abivax
ABVX
−15.3%
A
argenx
ARGX
+7.9%
A
Aurinia Pharmaceuticals
AUPH
+1.2%
A
Autolus Therapeutics
AUTL
−14.0%
B
Bambusa Therapeutics
BBTX
E
Electra Therapeutics
ETRA
L
Lakefront Biotherapeutics
LKFT
+5.2%
L
Lycia Therapeutics
LYCA
M
Mesoblast
MESO
−15.5%
M
MoonLake Immunotherapeutics
MLTX
−2.1%
N
Novartis
NVS
+23.7%
R
Roche Holdings
RHHBY
+21.9%
R
Roivant Sciences
ROIV
+85.4%